A total of 115 patients with advanced NSCLC receiving anti-PD-1 immunotherapy were included, and PCSK9 expression in baseline NSCLC tissues was detected using immunohistochemistry (IHC). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.